Re: Zenith trial partners
in response to
by
posted on
Feb 02, 2023 04:24PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
please, you post your debbie downer/karen crap so don't try & flip it - your no different than little john far as i can tell.
did you get out today , you were going to be "gobsmack" at a .20 buy out - take a hike or put on ignore.
thats your post mr gobsmack - deal with it & choke on your .20 cheap bti shares you thanked people for giving you while your at it.
there your posts , not mine karenĀ